Parallel Advisors »

Crinetics Pharmaceuticals In shares owned by Parallel Advisors

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 1.6k 46.81
2023-12-31 $16k 439 35.58
2022-09-30 $0 6 0.00
2021-09-30 $0 6 0.00

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Guggenheim Etf Trust S&p 500 Equal Weight Etf (RSP)
Ishares Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)

View all positions for Parallel Advisors

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Lord, Abbett & Co
Ikarian Capital
Goldman Sachs Group

View all funds holding Crinetics Pharmaceuticals In